about
sameAs
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaClinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal CancerA Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesFolfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic CancerPreoperative Radiotherapy and E7046 in Rectum CancerFOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon CancerA Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal CancerUracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal CancerA Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOXBevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCombination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryStudy Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer TherapyStereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic CancerCombination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic CancerEfficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver MetastasesAn Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric AdenocarcinomasStudy of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic TargetsModified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric CancerMaintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal CancerChemotherapy for Relapsed Epstein Barr Virus Associated LymphomaFOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal CancerPostoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal CancerTranshepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal CancerStudy of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver MetastasesStudy of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) SubjectsA Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal CancerA Study of IMC-1121B (Ramucirumab) in Colorectal CancerRadiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal CancerCelecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal CancerFolinic Acid in AutismFOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer PatientsDisulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or GemcitabineNeoadjuvant Therapy Followed by Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Pancreatic CancerCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCombination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell LymphomaCombination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic LeukemiaSWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically RemovedRechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal CancerTS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC
P4844
Q61864749-49441070-E2C6-4A6E-9F20-129A69AFF2D5Q61894487-11FA5DA7-9922-4E7C-850F-729D46E25FA3Q61907114-CD657755-E2F8-4E89-A0DA-AC30660FC658Q61907694-50E19C60-2258-42B4-BE23-E4F2AF3323ABQ61909913-8AD5A4CC-EDA2-461C-A088-CA9F26D7D72AQ61914328-5D0A858E-5136-43E8-BD1E-F68BA6A19AD7Q61915309-A7167A12-CDC9-4EE1-902E-90B8811B11F1Q61917437-BB1D07AE-025A-4C01-A645-888E75F15B0BQ61917723-8CEE7C96-C8ED-4DD4-972C-B43F021B273CQ61921674-25F4439F-0828-4E7C-9599-7282BEC18344Q61922361-0AE5BABB-BF76-48BB-891D-15D066818564Q61936979-221528EF-88EE-4469-BC51-BE1289764662Q61939053-B4EF7AD8-44A6-4469-A98C-97278E9018B4Q61955362-F4934EB1-470A-49F4-9272-E76FDCA0DDDCQ61956650-175519C1-32C9-484D-BFD9-1229C0FB30E5Q61956987-923F73EE-B30E-4B7B-8869-F339408201A0Q61957309-2A3D2E83-EA2E-4F32-8CB2-5B2D8E15CAB3Q61966675-D32DA591-544A-4E46-9B17-C33D52987A6AQ61969157-246B1E06-3C9B-44A3-9AB8-E1286AFD8F6DQ61969986-70B7654B-1D4E-4949-BE7F-608386F0A55EQ61975817-E9E7CC8A-D165-45A8-B8E4-E813A3C503C4Q61980341-B1FC6A95-CC90-457C-AE21-5B8C3AC3D597Q61980738-46564B9F-8F4A-439E-86F2-3FC791E797E8Q61980798-EB618B26-544F-4785-807C-778A3D040D8CQ61980942-D3968475-DA70-4404-BB91-D9CD911ECA0CQ61981047-0C557D9B-329A-4CFE-8928-62C2F7EA5609Q61981094-87ECB3D4-9195-4A1B-87A5-D7285E3CC95BQ61981294-815798B1-EBCA-4E86-8130-BC6E98FEF4ACQ61981439-D0DD1EEC-BBF9-49FF-9EAF-CD1BBCA0FF31Q62025847-DAFFD1EB-556E-402E-9B31-E4FB6DF05264Q62031245-77BCD9AD-5917-4AE7-A3AD-53220AC1F381Q62039627-EEC153CE-2437-40A4-A8F8-A52B2F89654DQ62041201-BBA86AF4-7863-475B-AAD8-4DDBEC8ECB6CQ62062884-FADA0ABD-74AA-4F3B-9EEA-734E07098D42Q62106060-BA46D9CF-5517-43A5-8E3C-B19727D94B0BQ62110209-BC0D69B0-2A0B-46DD-A556-D60A1A0B0C5BQ62110587-B198194C-B5A1-432C-97B7-CA3C196E838AQ62110779-C7CEFCBD-E3EE-4F1C-BE75-03A4E6A97D37Q62809756-2FFC80B5-96B4-4064-A8EB-2248E003E7D5Q62817382-51C3F0A9-425E-410D-86B8-30E06D66C46F
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Calciumfolinat
@de
leucovorin calcium
@en
type
label
Calciumfolinat
@de
leucovorin calcium
@en
altLabel
Folinsäure-Calciumsalz
@de
prefLabel
Calciumfolinat
@de
leucovorin calcium
@en
P592
P661
P662
P683
P2017
C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-].[Ca+2]
P2067
P2115
N0000147071
N0000184018
P231
P232
P233
C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Ca+2]
P234
1S/C20H23N7O7.Ca/c21-20-25-16- ...... 32);/q;+2/p-2/t12?,13-;/m0./s1
P235
KVUAALJSMIVURS-ZEDZUCNESA-L
P2566
100.014.621
P274
C₂₀H₂₁CaN₇O₇
P2892
P3117
DTXSID20872448
P3345
P592
CHEMBL1201138
P652
RPR1R4C0P4